Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.38M Buy
20,757
+569
+3% +$59.1K 0.19% 129
2023
Q3
$2.07M Buy
20,188
+4,611
+30% +$497K 0.19% 127
2023
Q2
$1.65M Buy
15,577
+1,815
+13% +$206K 0.15% 145
2023
Q1
$1.46M Buy
13,762
+6,624
+93% +$715K 0.16% 140
2022
Q4
$793K Buy
7,138
+4,527
+173% +$463K 0.13% 180
2022
Q3
$250K Sell
2,611
-491
-16% -$43.8K 0.11% 140
2022
Q2
$286K Buy
+3,102
New +$275K 0.12% 122
2020
Q1
Sell
-2,673
Closed -$234K 168
2019
Q4
$234K Sell
2,673
-362
-12% -$29.7K 0.15% 133
2019
Q3
$241K Sell
3,035
-635
-17% -$50.9K 0.2% 121
2019
Q2
$297K Sell
3,670
-582
-14% -$44.6K 0.28% 107
2019
Q1
$332K Buy
4,252
+84
+2% +$6.28K 0.36% 88
2018
Q4
$304K Buy
+4,168
New +$294K 0.4% 85

Other funds holding MRK

DFPG Investments's MRK Position: Q4 2023 in Review

DFPG Investments increased its Merck (MRK) stake by 2.8% in Q4 2023, buying an estimated $59.1K and bringing the position to 20,757 shares worth $2.38M. The position accounts for 0.19% of the portfolio, ranked #129.

DFPG Investments first reported a position in MRK in Q4 2018 and has held it in 12 quarters since. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • DFPG Investments held 20,757 shares of Merck worth $2.38M as of Q4 2023.
  • DFPG Investments bought 569 Merck shares in Q4 2023, an estimated $59.1K.
  • Merck made up 0.19% of DFPG Investments's portfolio in Q4 2023, its #129 holding.
  • DFPG Investments first reported a position in Merck in Q4 2018 and has held it in 12 quarters since.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.